The MHA hosted a one-hour Twitter chat March 4 to discuss Emergency Department (ED) Medication for Opioid Use Disorder (MOUD). The chat allowed participants to engage with their peers and share information and resources related to ED MOUD, as many of these programs help address stigma and increase access to effective treatment for opioid use disorder.
The MHA moderated the chat as participants, including the MHA Keystone Center, the Community Foundation of Southeast Michigan (CFSEM), MHA leadership, and members of the Michigan Opioid Partnership answered questions using the hashtags #MHAHealthChat, #MOUD and #MAT. The chat gathered more than 4,200 impressions (the number of times content from the conversation was seen) and a potential reach of more than 6,400 users. Additional engagements came from the Michigan Department of Health & Human Services (MDHHS), Beaumont Health, the Michigan Association of Health Plans and the Michigan Primary Care Association.
The Twitter chat follows an announcement of an ED MOUD initiative and funding opportunity for Michigan hospitals launched by the CFSEM in partnership with the MHA Keystone Center, the Michigan Opioid Partnership and the MDHHS. The initiative aims to increase access to evidence-based medication for opioid use disorder and support the transition to long-term, office-based treatment upon discharge. Applications are being accepted on a rolling basis until April 22. For the most current information, application instructions and grant guidelines, visit the CFSEM website, or contact the MHA Keystone Center to learn more.
In partnership with the MHA Keystone Center, Michigan Opioid Partnership and the Michigan Department of Health and Human Services, the Community Foundation for Southeast Michigan (CFSEM) has launched an Emergency Department (ED) Medication for Opioid Use Disorder Initiative and funding opportunity for Michigan hospitals. The initiative aims to increase access to evidence-based medication for opioid use disorder and support the transition to long-term, office-based treatment upon discharge. More information about the initiative is available in an online video.
The next application cycle will open Jan. 3 and close Jan. 21. Additional application cycles during the award period, which ends Sept. 30, will depend upon remaining funding. Grant funds are limited and are available on a first-come, first-served basis.
Eligibility will be determined by the number of encounters each hospital has annually to treat patients for opioid-related overdoses. Eligible hospitals are encouraged to coordinate and apply as a system. If two or more eligible hospitals from the same system are interested in applying, they are encouraged to contact the CFSEM to discuss the possibility of applying as a system. Eligibility for grant funding is outlined as follows:
- Hospitals with more than 100 encounters annually are eligible for technical assistance and up to $150,000.
- Hospitals with 50-100 encounters annually are eligible for technical assistance and up to $75,000.
- Hospitals with fewer than 50 encounters annually are eligible for technical assistance and are strongly encouraged to contact the CFSEM if interested. Currently, hospitals with fewer than 50 encounters annually are ineligible for funding.
Application instructions and grant guidelines are available on the CFSEM website, and future application cycles will be posted there. Members may contact the MHA Keystone Center with questions and email CFSEM to learn more or to request a meeting to discuss this opportunity.
The MHA Keystone Center is working alongside the Community Foundation for Southeast Michigan (CFSEM) through the Michigan Opioid Partnership to provide funding and technical assistance for the emergency department-based medication for opioid use disorder (ED MOUD) program. The program will increase access to medication for OUD statewide and connect patients receiving MOUD with appropriate resources to continue care in the community. An online video provides additional information on the program.
The CFSEM recently released impact stories highlighting successes of the program from previous participants. Andrew King, MD, an emergency room physician at Detroit Medical Center and advisor to the CFSEM, has witnessed the effectiveness of MOUD and reminds practitioners that it is possible to guide those with OUD down a path to recovery.
“I can see the people who are now on medications and feeling much better and doing well. They are happy and putting their lives back together, and that’s a beautiful thing!” King says. “By controlling the disease process, maybe they’re treating their kids or their spouse better or they’re doing a better job at work. That’s the whole point of why we signed up for this job — trying to keep people safe and healthy and in the game for as long as possible.” An article from the CFSEM provides additional information.
The MHA has also been advocating to improve legislation related to ED MOUD by working with the Michigan Department of Health and Human Services to ensure all hospitals interested in starting an emergency department-based medication assisted treatment program have the funding resources to do so.
Members with questions on the ED MOUD program may contact the MHA Keystone Center.